I consider SSAs as the first-choice treatment instead of surgery, for growth hormone secreting pituitary adenoma without visual pathway structure compression, but with a low probability of complete resection (invasive macroadenomas (Knosp grade III–IV). The gene discussed is GH1; the disease is pituitary gland adenoma.